It's a good start, certainly good for Gilead and the wealthy who can afford it. The trouble is that the synthesis is a multistep horror that is difficult to sca

It's a good start, certainly good for Gilead and the wealthy who can afford it. The trouble is that the synthesis is a multistep horror that is difficult to scale up. There is a step to install the nitrile group, which seems to be required, which takes place at dry-ice temperature. And you need gram amounts per patient and the drug comes as a lyophilized powder, to be reconstituted and taken by injection. Not a game-changer, when you have millions infected, many in poor parts of the world.